Diabetes Mellitus, Type 2
Conditions
Interventions
This is a three-arm, triple-blind, randomized controlled clinical trial. Participants will be randomly allocated using opaque envelopes previously numbered by researchers who do not directly participa
G07.203.300.456.249.500
G11.427.410.698.277
Sponsors
AMC Serviços Educacionais S/C Ltda
Laboratório do Estudo do Movimento (LEM) do Instituto de Ortopedia e Traumatologia (IOT) do Hospital das Clínicas (HC) da Faculdade de Medicina da Universidade de São Paulo
Eligibility
Sex/Gender
Male
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Men; at least 60 years of age; have a diagnosis of Type 2 Diabetes Mellitus; have been under medical supervision with a stable dose of medication (oral antidiabetics or insulin or a combination of both) for three or more months; have glycated hemoglobin (HBA1c) between 6 and 9.0%; have no impairment of the musculoskeletal system such as pain and any type of disabling disease or previous surgeries; do not have a chronic non-communicable disease not specifically treated and decompensated; be vaccinated against COVID-19
Exclusion criteria
Exclusion criteria: Failure to complete assessments and reassessments; absence more than three times during the training period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Knee flexor and extensor muscle strength | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of body mass, wheight, body composition, physical performance, dynamic balance, bowel habits, microbiota composition, oxidative stress and inflammatory pattern | — |
Countries
Brazil
Contacts
Public ContactPriscila Longo
Universidade São Judas Tadeu
Outcome results
None listed